Alivus Life Sciences Ltd.

Glenmark Life Sciences has informed that, India Ratings has discontinued and withdrawn the outstanding voluntary issuer rating disclosure of the company due to regulatory requirement. All outstanding instrument ratings remain unaffected and this action should not be construed as a change to the credit profile of the Company. The detailed report is attached.

The above information is a part of company’s filings submitted to BSE.